Investors are Digesting These Healthcare Stock Earnings Insights

  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased to $-0.65 in the quarter versus EPS of $-0.23 in the year-earlier quarter. Revenue Rose 35.12% to $19.43 million from the year-earlier quarter.

Optimer Pharmaceuticals, Inc. reported adjusted EPS loss of $0.65 per share. By that measure, the company missed the mean analyst estimate of $-0.42. It missed the average revenue estimate of $21.09 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

OPTR

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business